Study of Naltrexone for Methamphetamine Addiction

Completed · Phase 2

Conditions studied: Methamphetamine Dependence

In brief

The purpose of this study is to determine whether methamphetamine-dependent individuals will use less methamphetamine when treated with naltrexone. The study will also investigate whether individuals with the mu opioid receptor gene variant A118G will use less methamphetamine than individuals without A118G.

Key facts

Study ID

NCT00984360

Run by

California Pacific Medical Center Research Institute

People needed

22

Starts

2009-09-01

Expected to finish

2012-09-01

Last updated by the study team

2013-05-31

Who can join

Age: 18 and older, up to 50. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age between 18 and 50 years
• Patient is agreeable to conditions of study and signs consent form

Where it is running

• Addiction & Pharmacology Research Laboratory — San Francisco, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.